MedTrace Logo

Application of Vibration Wave Therapy to the Children Suffering From Cerebral Palsy and Tongue Spastic Dysarthria

NCT04222049 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2020-06-16

No results posted yet for this study

Summary

Vibration therapy is the widely used in many neurological disorders for different type of problems. Recently, it is being used by researchers for the betterment of motor disorders and muscle movements of the cerebral palsy patients and significant results are obtained. Investigators are conducting this research to explore that whether this therapy can have some effect on the Spastic Tongue Dysarthria of the Cerebral Palsy patients.

Conditions

  • Cerebral Palsy
  • Spastic Dysarthria

Interventions

DEVICE

Vibro Tactile Gadget

The concept is to apply vibro tactile gadget to different nerve points which when applied transmit waves to the focused parts of brain which will result in blood flow and activation of dead cells. As a result some disabled part of the body because of those dead cells can show improvement.

Sponsors & Collaborators

  • Family Health Hospital Islamabad Pakistan

    collaborator UNKNOWN

  • Higher Education Commission (Pakistan)

    collaborator OTHER

  • National University of Science and Technology, Pakistan

    lead OTHER

Principal Investigators

  • Shahbaz K Ranjha, MPhil · Family Health Hospital Islamabad

  • Aliya A Khan, MS · National University of Science & Technology

  • Mohammad U Akram, Phd · National University of Science & Technology

  • Madeeha Nissar, MSc · Isra University Islamabad

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-15
Primary Completion
2020-05-12
Completion
2020-06-14

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04222049 on ClinicalTrials.gov